Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ovid Therapeutics Inc. | 1,435,000 | reported | 26 Feb 2026 | tx 8+2,778,060−16,935 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Feb 2026 | SALE | Ovid Therapeutics Inc. | 11,656 | 1.45 USD | |
| 26 Feb 2026 | GRANT_AWARD | Ovid Therapeutics Inc. | 1,435,000 | 0.00 USD | deriv |
| 04 Jan 2026 | GRANT_AWARD | Ovid Therapeutics Inc. | 890,000 | 0.00 USD | deriv |
| 26 Feb 2025 | SALE | Ovid Therapeutics Inc. | 5,279 | 0.56 USD | |
| 20 Feb 2025 | GRANT_AWARD | Ovid Therapeutics Inc. | 43,750 | 0.00 USD | |
| 20 Feb 2025 | GRANT_AWARD | Ovid Therapeutics Inc. | 262,500 | 0.00 USD | deriv |
| 27 Jan 2025 | PURCHASE | Ovid Therapeutics Inc. | 6,810 | 0.73 USD | |
| 09 Sept 2024 | GRANT_AWARD | Ovid Therapeutics Inc. | 140,000 | 0.00 USD | deriv |